

Translating Science
into Nutraceutical Ingredients
Nutra-it is a healthcare R&D company that creates value for human health through scientific research. Through technological innovation, we develop differentiated nutraceutical ingredients to support health and well-being.
Vision & Values
Advancing human healththrough world-class R&D

Ethical Management
Upholding integrity and transparency in everything we do
Technological Innovation
Creating future value through differentiated R&D
Globalization
Expanding our presence in markets around the world
Responsible Management
Taking responsibility for the safety and quality of our ingredients
Team

Sam Cho, PhD
CEO
6YEARSWITH NUTRA-IT

Sunny Kim, PhD
Research DirectorR&D Center
6YEARSWITH NUTRA-IT

Chloe Choi
Principal Research ScientistR&D Center
5YEARSWITH NUTRA-IT

Yuri Jeong
Research ScientistR&D Center
2YEARSWITH NUTRA-IT
History
2021
- 02Nutra-it Inc. founded
- 05Selected for the K-Startup support program [KRW 100M]
2022
- 04Investment secured [KRW 100M / Chungbuk Center for Creative Economy & Innovation]
- 07Selected for the TIPS R&D program [KRW 500M]
- 07Investment secured [KRW 100M / private investors]
- 09Certified as a venture company
2023
- 05Investment secured [KRW 500M / Magna Investment]
2024
- 01Corporate R&D Center established
- 11Selected for the TIPS Overseas Marketing Support Program [KRW 110M]
2025
- 05BENESOMNO™ (lime peel extract) approved as an individually recognized functional ingredient by the MFDS
- 09BENESOMNO™ (lime peel extract) listed as a New Dietary Ingredient (NDI) with the U.S. FDA
- 09Selected for the TIPS Startup Commercialization Program [KRW 120M]
- 10BENESOMNO™ exhibited at the SSG 2025 New Product Zone
- 12Investment secured [KRW 1.5B / Magna Investment]
- 12Achieved annual revenue of KRW 1B
2026
- 01BENESOMNO™ exported to China
- 01BENESOMNO™ exported to Taiwan
- 04BENESOMNO™ exported to the United States
- 04Completed commercial-scale production of BENESOMNO-X™ (a new functional ingredient)
- 04Completed commercial-scale production of EVERLIME™ (a cosmetic ingredient)
- 06Won the Young Prize [World FoodTech ConfEx]
- 08BENESOMNO™ exported to Malaysia
- 09Selected for the Scale-up TIPS (specialized track) R&D program [KRW 4B]
- 11Received the Jang Young-sil Award (lime peel extract, BENESOMNO™)
R&D Pipeline
Nutra-it discovers ingredients that support health and beauty and conducts R&D from efficacy and safety evaluation to mechanism-of-action studies and ingredient development. Our goal is to systematically evaluate the bioactivity and safety of naturally derived materials and develop them into differentiated functional ingredients.
Our nutraceutical research focuses on sleep, stress and cognitive function—key areas related to the nervous system and quality of life. We evaluate the bioactivity and safety of naturally derived materials, investigate their mechanisms of action and validate their health benefits through human clinical trials. Through this research, we develop functional ingredients to support health and quality of life.
Our cosmetic research explores the effects of natural materials on skin biology. We develop evidence-based cosmetic ingredients through efficacy and safety evaluation and formulation feasibility studies.

- Lime peel extract
- Sleep-support ingredient
- MFDS recognition as a functional ingredient (2025)
- U.S. FDA NDI notification (2025)
- Additional human clinical trials in progress

- High-purity lime flavonoids
- Human clinical trial in progress
- Regulatory approvals underway in Korea and abroad

- Lime-derived cosmetic ingredient
- Research on skin benefits
Future Pipeline
- Ingredient for menopausal support
- Exploring new health benefits
- Pipeline expansion through technology in-licensing
Research Network
Universities
Keck School of Medicine of USC
The University of Tokyo
Fudan University
Pukyong National University
Sejong University
Dong-eui University
Research Institutes
Institute for Basic Science
Korea Institute of Science and Technology
Korea Health Functional Food Research Institute
Korea Food Research Institute
National R&D Projects
| No. | Project | Supporting Agency | Period | Budget(KRW million) |
|---|---|---|---|---|
| 1 | Early Startup Package | Ministry of SMEs and Startups | 2021.05 ~ 2022.02 | 100 |
| 2 | SME Technology Development Program (TIPS) | Ministry of SMEs and Startups | 2022.07 ~ 2024.12 | 550 |
| 3 | TIPS Overseas Marketing Support Program | Ministry of SMEs and Startups | 2024.11 ~ 2025.08 | 110 |
| 4 | TIPS Startup Commercialization Program | Ministry of SMEs and Startups | 2025.09 ~ 2026.06 | 120 |
| 5 | Scale-up TIPS (Specialized Track) | Ministry of SMEs and Startups | 2026.09 ~ 2029.08 | 4,000 |
1Early Startup Package
- Supporting Agency
- Ministry of SMEs and Startups
- Period
- 2021.05 ~ 2022.02
- Budget (KRW million)
- 100
2SME Technology Development Program (TIPS)
- Supporting Agency
- Ministry of SMEs and Startups
- Period
- 2022.07 ~ 2024.12
- Budget (KRW million)
- 550
3TIPS Overseas Marketing Support Program
- Supporting Agency
- Ministry of SMEs and Startups
- Period
- 2024.11 ~ 2025.08
- Budget (KRW million)
- 110
4TIPS Startup Commercialization Program
- Supporting Agency
- Ministry of SMEs and Startups
- Period
- 2025.09 ~ 2026.06
- Budget (KRW million)
- 120
5Scale-up TIPS (Specialized Track)
- Supporting Agency
- Ministry of SMEs and Startups
- Period
- 2026.09 ~ 2029.08
- Budget (KRW million)
- 4,000
Publications
| No. | View Paper | Title | Journal | SCI(E) | IF | Year |
|---|---|---|---|---|---|---|
| 1 | View Paper | Novel neuropharmacological activity of citrus lime (Citrus aurantifolia): A standardized lime peel supplement enhances non-rapid eye movement sleep by activating the GABA type A receptor | Biomedicine & Pharmacotherapy | SCI(E) | 7.5 | 2024 |
| 2 | View Paper | Efficacy and safety of standardized lime peel supplement in adults with sleep disturbance: A randomized, double-blind, placebo-controlled, polysomnographic study | Phytomedicine | SCI(E) | 11.3 | 2025 |
| 3 | View Paper | Regulatory safety evaluation of key lime (Citrus aurantiifolia) peel ethanol extract: Acute, 90-day repeated-dose, and genotoxicity studies | Regulatory Toxicology and Pharmacology | SCI(E) | 4.3 | 2026 |
1Novel neuropharmacological activity of citrus lime (Citrus aurantifolia): A standardized lime peel supplement enhances non-rapid eye movement sleep by activating the GABA type A receptor
Biomedicine & Pharmacotherapy
SCI(E) · IF 7.5 · 2024
2Efficacy and safety of standardized lime peel supplement in adults with sleep disturbance: A randomized, double-blind, placebo-controlled, polysomnographic study
Phytomedicine
SCI(E) · IF 11.3 · 2025
3Regulatory safety evaluation of key lime (Citrus aurantiifolia) peel ethanol extract: Acute, 90-day repeated-dose, and genotoxicity studies
Regulatory Toxicology and Pharmacology
SCI(E) · IF 4.3 · 2026
Patents
Domestic
| No. | Certificate | Title of Invention | Status | Registration (Application) No. | Date |
|---|---|---|---|---|---|
| 1 | Composition for preventing, ameliorating or treating sleep disorder or insomnia, containing extract of roasted citrus byproduct as active ingredient | Registered | 10-2569228 | 2023.08.17 | |
| 2 | Applied | Composition for anti-depression, anti-anxiety, anti-stress or relaxation, containing extract of roasted lime byproduct as active ingredient | Filed | 10-2025-0042497 | 2025.04.02 |
| 3 | Applied | Composition for improving liver function, containing extract of roasted lime byproduct as active ingredient | Filed | 10-2025-0042498 | 2025.04.02 |
| 4 | Applied | Method for producing a purified flavonoid from extract of roasted citrus byproduct, purified flavonoid produced thereby, and its use as active ingredient for preventing sleep disorder or insomnia | Filed | 10-2026-0042949 | 2026.03.10 |
1Composition for preventing, ameliorating or treating sleep disorder or insomnia, containing extract of roasted citrus byproduct as active ingredient
- Status
- Registered
- Registration (Application) No.
- 10-2569228
- Date
- 2023.08.17
- Applied
2Composition for anti-depression, anti-anxiety, anti-stress or relaxation, containing extract of roasted lime byproduct as active ingredient
- Status
- Filed
- Registration (Application) No.
- 10-2025-0042497
- Date
- 2025.04.02
- Applied
3Composition for improving liver function, containing extract of roasted lime byproduct as active ingredient
- Status
- Filed
- Registration (Application) No.
- 10-2025-0042498
- Date
- 2025.04.02
- Applied
4Method for producing a purified flavonoid from extract of roasted citrus byproduct, purified flavonoid produced thereby, and its use as active ingredient for preventing sleep disorder or insomnia
- Status
- Filed
- Registration (Application) No.
- 10-2026-0042949
- Date
- 2026.03.10
International
| No. | Country | Certificate | Title of Invention | Status | Registration (Application) No. | Date |
|---|---|---|---|---|---|---|
| 1 | USA | Applied | COMPOSITION FOR PREVENTING, AMELIORATING OR TREATING SLEEP DISORDER OR INSOMNIA, CONTAINING EXTRACT OF ROASTED CITRUS BYPRODUCT AS ACTIVE INGREDIENT | Filed | 18033699 | 2023.04.25 |
| 2 | China | Applied | COMPOSITION FOR PREVENTING, AMELIORATING OR TREATING SLEEP DISORDER OR INSOMNIA, CONTAINING EXTRACT OF ROASTED CITRUS BYPRODUCT AS ACTIVE INGREDIENT | Filed | 202280020678.9 | 2023.10.09 |
| 3 | Europe | Applied | COMPOSITION FOR PREVENTING, AMELIORATING OR TREATING SLEEP DISORDER OR INSOMNIA, CONTAINING EXTRACT OF ROASTED CITRUS BYPRODUCT AS ACTIVE INGREDIENT | Filed | EP22911933.4 | 2023.05.01 |
| 4 | PCT | Applied | Composition for anti-depression, anti-anxiety, anti-stress or relaxation, containing extract of roasted lime byproduct as active ingredient | Filed | PCT/KR2026/095399 | 2026.04.01 |
- Applied
1COMPOSITION FOR PREVENTING, AMELIORATING OR TREATING SLEEP DISORDER OR INSOMNIA, CONTAINING EXTRACT OF ROASTED CITRUS BYPRODUCT AS ACTIVE INGREDIENT
- Country
USA- Status
- Filed
- Registration (Application) No.
- 18033699
- Date
- 2023.04.25
- Applied
2COMPOSITION FOR PREVENTING, AMELIORATING OR TREATING SLEEP DISORDER OR INSOMNIA, CONTAINING EXTRACT OF ROASTED CITRUS BYPRODUCT AS ACTIVE INGREDIENT
- Country
China- Status
- Filed
- Registration (Application) No.
- 202280020678.9
- Date
- 2023.10.09
- Applied
3COMPOSITION FOR PREVENTING, AMELIORATING OR TREATING SLEEP DISORDER OR INSOMNIA, CONTAINING EXTRACT OF ROASTED CITRUS BYPRODUCT AS ACTIVE INGREDIENT
- Country
Europe- Status
- Filed
- Registration (Application) No.
- EP22911933.4
- Date
- 2023.05.01
- Applied
4Composition for anti-depression, anti-anxiety, anti-stress or relaxation, containing extract of roasted lime byproduct as active ingredient
- Country
PCT- Status
- Filed
- Registration (Application) No.
- PCT/KR2026/095399
- Date
- 2026.04.01
HQ & R&D center
BENESOMNO™ (Lime Peel Extract) Inquiries
benesomno@nutra-it.com- mjkim@nutra-it.com
- Address
- 301, 3F, 60 Godeokbizvalley-ro, Gangdong-gu, Seoul 05203, Korea
Busan Branch
- mjkim@nutra-it.com
- Address
- 1108, C15 bldg, Yongso-ro 45, Nam-gu, Busan 48513, Republic of Korea
Global Partners
BENESOMNO™ is expanding worldwide with distribution partners in key global markets.





